Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model
10.1128/AAC.03274-14
Saved in:
Main Authors: | Lakshminarayana S.B., Freymond C., Fischli C., Yu J., Weber S., Goh A., Yeung B.K.S., Ho, Chi Lui Paul, Dartois V., Diagana T.T., Rottmann M., Blasco F. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
American Society for Microbiology
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/123270 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Spiroindolone KAE609 for falciparum and vivax malaria
by: Nicholas J. White, et al.
Published: (2018) -
A first-in-human randomized, double-blind, placebo-controlled, single- And multiple-ascending oral dose study of novel antimalarial spiroindolone KAE609 (cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers
by: Leong, F.J, et al.
Published: (2020) -
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosis
by: Lakshminarayana S.B., et al.
Published: (2018) -
Spiroindolones, a potent compound class for the treatment of malaria
by: Matthias Rottmann, et al.
Published: (2018) -
Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model
by: Pornpan Koomanachai, et al.
Published: (2018)